|
![]() |
|
|
Phenelzine: profile and news
Medicine mix kills man, 40 May 4, 2006 Other information Indication Indicated in the treatment of depression. Pharmacology Phenelzine belongs to a class of antidepressants called monoamine oxidase inhibitors (MAOIs). Phenelzine works by irreversibly blocking the action of a chemical substance known as monoamine oxidase (MAO) in the nervous system. Within neurons, MAO appears to regulate the levels of monoamines released upon synaptic firing. Since depression is associated with low levels of monoamines, the inhibition of MAO serves to ease depressive symptoms. Mechanism Of Action The irreversible inhibition of MAO by Phenelzine causes an increase in the levels of serotonin, norepinephrine, and dopamine in the neuron, relieving depressive symptoms. Drug Category Antidepressants; ATC:N06AF03 Brand Names/Synonyms Beta-Phenylethylhydrazine; CHEMBANK3273; Fenelzina [Inn-Spanish]; Fenelzyna; Fenelzyna [Polish]; Fenelzyne; Fenelzyne [Polish]; Hydrazine, Phenethyl-; Nardil; Phenalzine; Phenelezine; Phenelzine; Phenelzinum [Inn-Latin]; Phenethylhydrazine; Phenylethyl Hydrazine-Hcl; Phenylethylhydrazine; Stinerval; W-1544; W1544 Dosage Forms TABLET Absorption Readily absorbed after oral administration. Interactions Interactions for Phenelzine: In patients receiving nonselective monoamine oxidase (MOA) inhibitors in combination with serotoninergic agents (e.g., dexfenfluramine, fluoxetine, fluvoxamine, paroxetine, sertraline, venlafexine) there have been reports of serious, sometimes fatal, reactions. Because Nardil is a monoamine oxidase (MAO) inhibitor, Nardil should not be used concomitantly with a serotoninergic agent. Chemical IUPAC Name 2-hydrazinylethylbenzene Chemical Formula C8H12N2 Half Life Not Available Drug Type Approved Drug # Accession No APRD00099 CAS Registry Number 51-71-8 |
|
Home | About | Cancers | Treatment | Medications Copyright onconews.org 2005. All Rights Reserved. |